We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+21.54%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$6.08B
AUM Growth
+$375M
Cap. Flow
-$205M
Cap. Flow %
-3.37%
Top 10 Hldgs %
23.61%
Holding
263
New
25
Increased
137
Reduced
69
Closed
23

Top Buys

Rank Stock Value
1
SLNO
Soleno Therapeutics
SLNO
+$34.7M
2
TLN
Talen Energy Corp
TLN
+$29.8M
3
ABVX
Abivax
ABVX
+$24.3M
4
EVH icon
Evolent Health
EVH
+$21.4M
5
PLD icon
Prologis
PLD
+$16.2M

Top Sells

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$212M
2
BPMC
Blueprint Medicines
BPMC
+$93.4M
3
WDAY icon
Workday
WDAY
+$28M
4
RELY icon
Remitly
RELY
+$27M
5
INSM icon
Insmed
INSM
+$23.4M

Sector Composition

Rank Sector Weight
1 Healthcare 37.53%
2 Industrials 18.58%
3 Technology 17.54%
4 Consumer Discretionary 8.04%
5 Utilities 5.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MTG icon
226
MGIC Investment
MTG
$6.25B
$434K 0.01%
15,254
+2,482
+19% +$67.6K
KVUE icon
227
Kenvue
KVUE
$36.3B
$434K 0.01%
26,535
-7,774
-23% -$159K
AER icon
228
AerCap
AER
$24.2B
$405K 0.01%
3,337
+937
+39% +$109K
EXPD icon
229
Expeditors International
EXPD
$22.2B
$401K 0.01%
3,264
+564
+21% +$67.1K
PAYC icon
230
Paycom
PAYC
$7.86B
$392K 0.01%
1,796
-2,370
-57% -$534K
LW icon
231
Lamb Weston
LW
$7.32B
$370K 0.01%
6,643
+1,086
+20% +$59.4K
APTV icon
232
Aptiv
APTV
$12.1B
$359K 0.01%
+4,189
New +$316K
MANH icon
233
Manhattan Associates
MANH
$11.1B
$356K 0.01%
1,715
-4,631
-73% -$979K
DECK icon
234
Deckers Outdoor
DECK
$13.5B
$333K 0.01%
+3,228
New +$352K
DT icon
235
Dynatrace
DT
$13B
$310K 0.01%
6,287
-23,547
-79% -$1.19M
OKTA icon
236
Okta
OKTA
$24.9B
$310K 0.01%
3,299
+459
+16% +$42.9K
TW icon
237
Tradeweb Markets
TW
$21.2B
$298K ﹤0.01%
2,676
-8,213
-75% -$1.06M
EW icon
238
Edwards Lifesciences
EW
$51B
$247K ﹤0.01%
3,201
– –
CP icon
239
Canadian Pacific Kansas City
CP
$79.3B
$217K ﹤0.01%
2,949
-1,912
-39% -$146K
AIP icon
240
Arteris
AIP
$1.39B
– –
-195,314
Closed -$1.86M
AVB icon
241
AvalonBay Communities
AVB
$26.9B
– –
-68,675
Closed -$14M
AVPT icon
242
AvePoint
AVPT
$2.84B
– –
-44,482
Closed -$859K
BHVN icon
243
Biohaven
BHVN
$2.03B
– –
-300,000
Closed -$4.23M
BPMC
244
DELISTED
Blueprint Medicines
BPMC
– –
-728,821
Closed -$93.4M
BRKR icon
245
Bruker
BRKR
$9.78B
– –
-272,324
Closed -$11.2M
CAVA icon
246
CAVA Group
CAVA
$7.54B
– –
-2,710
Closed -$212K
CFLT
247
DELISTED
Confluent
CFLT
– –
-46,047
Closed -$1.15M
CPRT icon
248
Copart
CPRT
$27.2B
– –
-11,823
Closed -$570K
ELS icon
249
Equity Lifestyle Properties
ELS
$12.8B
– –
-145,449
Closed -$8.97M
EMR icon
250
Emerson Electric
EMR
$86.4B
– –
-6,288
Closed -$837K
7 8 9
10
11

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q3 2025 Portfolio in Review

As of Q3 2025, Eventide Asset Management held 263 positions worth $6.08B, up 6.6% from $5.71B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Eventide Asset Management withdrew a net $205M in Q3 2025, closing 23 positions and reducing 69 holdings. Its most notable exit was Blueprint Medicines, an estimated $93.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 37% a quarter earlier, followed by Industrials and Technology.

Against the trend, Eventide Asset Management opened a new position in Soleno Therapeutics worth $31.6M.

  • Eventide Asset Management's largest Q3 2025 buy was Soleno Therapeutics: 467,435 shares worth $31.6M.
  • Eventide Asset Management added most to Talen Energy Corp in Q3 2025, an estimated $29.8M increase.
  • Eventide Asset Management's biggest Q3 2025 reduction was Verona Pharma, cutting an estimated $212M.
  • Eventide Asset Management fully exited Blueprint Medicines in Q3 2025, selling an estimated $93.4M.
  • Eventide Asset Management's ten largest holdings make up 24% of its $6.08B portfolio in Q3 2025.
  • Eventide Asset Management opened 25 new positions and closed 23 in Q3 2025.
  • Eventide Asset Management's portfolio value rose 6.6% quarter-over-quarter to $6.08B.

Based on Eventide Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.